Safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in hepatitis C virus/human immunodeficiency virus co-infected patients

doi:10.4254/wjh.v9.i30.1190

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 30

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8241)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

321

WORD

246

HTML

2731

Figures (1-1)

246

Tables (1-3)

273

Sum=3817

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

631

Download

1121

Sum=1752

Publishing Process of This Article

Item

Count

Browse

951

Download

1721

Sum=2672

Oct 28, 2017 (publication date) through Dec 26, 2024

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Oct 28, 2017; 9(30): 1190-1196
Published online Oct 28, 2017. doi: 10.4254/wjh.v9.i30.1190

Full Size Figure Download Figure

Figure 1 Lab changes during treatment. A: Changes in liver function tests; B: Changes in serum creatinine level; C: Changes in GFR level; D: Changes in CD4 cell count.

Citation: He X, Hopkins L, Everett G, Carter WM, SchroppDyce C, Abusaada K, Hsu V. Safety and efficacy of ledipasvir/sofosbuvir on hepatitis C eradication in hepatitis C virus/human immunodeficiency virus co-infected patients. World J Hepatol 2017; 9(30): 1190-1196
URL: https://www.wjgnet.com/1948-5182/full/v9/i30/1190.htm
DOI: https://dx.doi.org/10.4254/wjh.v9.i30.1190